A study identified heterozygous, high‐impact, likely loss‐of‐function variants in the KDR gene that were strongly associated with a reduced carbon monoxide transfer coefficient and an older age at diagnosis of PAH [91]. This evidence concerns the gene KDR and pulmonary arterial hypertension.